Pebblebrook Hotel Trust (PEB) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
8 Jul, 2026Executive summary
2024 results exceeded expectations, driven by strong resort and redeveloped property performance, with Adjusted EBITDA up 0.8% to $359.2M and Adjusted FFO per diluted share up 5% to $1.68.
Same-Property Total RevPAR increased 2.1% for the year, with both urban and resort gains and robust out-of-room spending.
Group and leisure demand rebounded, especially at California resorts, with occupancy and RevPAR gains.
Operational efficiencies and cost controls mitigated inflationary pressures, supporting EBITDA growth.
Pebblebrook Hotel Trust shifted its portfolio toward higher-quality, leisure-focused properties, increasing group and leisure demand and reducing reliance on business transient travel.
Financial highlights
Q4 Same-Property Total RevPAR up 1.8%, with 4% growth at resorts and 0.7% at urban hotels, despite storm and renovation impacts.
Adjusted EBITDA for Q4 reached $62.7M, aided by $5.4M in business interruption insurance proceeds.
Resort occupancy for Q4 rose 3.7 points to 65%; urban occupancy up 2.9 points to 68.1%.
Redeveloped properties saw Q4 occupancy up 4.7 points, RevPAR up 6.3%, and market share up 274 bps.
2024 net income was $0.0M, compared to a net loss of $74.3M in 2023.
Outlook and guidance
2025 outlook assumes normalization of resort rates, with no further meaningful declines expected.
Group room night pace up 3.8%, group ADR up 1.8%, and total combined pace up 6.9% in revenues on the books for 2025.
LA wildfires expected to reduce 2025 rooms revenue by $9M-$12M and total revenue by $12M-$16M, mainly in Q1.
2025 Same-Property Total RevPAR growth expected between 1.8% and 3.7%; Adjusted EBITDAre guidance is $341.5–$355.5M.
Capital investments projected at $65M-$75M in 2025, with similar levels in 2026 excluding major redevelopments.
Latest events from Pebblebrook Hotel Trust
- Q2 2024 outperformed on EBITDA and FFO, but RevPAR growth outlook was lowered amid ADR pressure.PEB
Q2 20248 Jul 2026 - Strong recovery outlook with significant EBITDA upside and shares trading below private-market NAV.PEB
Investor presentation24 Jun 2026 - Q1 2026 outperformed with robust EBITDA growth and a raised outlook amid macro risks.PEB
Q1 20261 May 2026 - Redevelopment, portfolio repositioning, and capital discipline drive EBITDA growth and value.PEB
Investor presentation28 Apr 2026 - Key votes include trustee elections, auditor ratification, and enhanced shareholder rights.PEB
Proxy filing17 Apr 2026 - Proxy covers trustee elections, auditor ratification, say-on-pay, and enhanced shareholder rights.PEB
Proxy filing17 Apr 2026 - 2025 beat guidance on adjusted metrics; 2026 targets EBITDA growth and margin expansion.PEB
Q4 20257 Apr 2026 - Proxy covers trustee elections, auditor ratification, say-on-pay, and key ESG and governance initiatives.PEB
Proxy filing26 Mar 2026 - Q3 net income rebounded, RevPAR rose 2.7%, but storms led to a lower 2024 outlook.PEB
Q3 202415 Jan 2026